Amazing work by talented PhD student (now a postdoc @sangerinstitute.bsky.social and @astrazeneca.com) @dannbiostda.bsky.social!
Measuring drug responses in PDX-derived tumor cells in real-time.
Fantastic collaboration with @ruedalab.bsky.social!
Walking the walk.
www.cell.com/cell-reports...
Fantastic first day of @helloeacr.bsky.social conference in Essen! Open by a Keynote by Nic McGranahan and sponsored by @embpo.org!
A crucial part of the project actually takes place in the exploration phase, where we must turn off judgment.. It was a pleasure to be on the "Better than Your Creator: on AI and Creativity" Podcast with Shirly Coifman to talk about the creative scientific process.
podcasts.apple.com/il/podcast/2...
One of the greatest privileges of my career has been to mentor amazing researchers that now run their own labs. Four of them just sent me this picture:
@hrazaalilab.bsky.social
@ruedalab.bsky.social
@stephensammut.bsky.social
and Alex Bruna @icr.ac.uk
Itai Yanai
Fig. 6: Mathematical model
@carloscaldas1960.bsky.social is always pushing towards better understanding of cancer! So proud and happy to have done the PhD with him and @ruedalab.bsky.social and contributed to their labs. Looking forward to our upcoming papers to be realised later on this year! @helloeacr.bsky.social
Saez Lab Xmas dinner! We are missing people but we had such a fantastic dinner! I am so happy to be part of this lab full of brilliant scientists! Looking forward to the upcoming years! 🎄🎅✨
P.S. I soooo much enjoyed the bumper cars! @saezlab.bsky.social @ebi.embl.org
Esmaeilishirazifard et al. present a high-throughput drug screening platform that
uses real-time bioluminescent monitoring to measure the viability of PDTX-derived
tumor cells during drug treatment. T...
www.cell.com
So proud of another #Caldasian @allanlui.bsky.social moving on to finish his Med Onc training in HK!
@caldaslab.bsky.social is made of amazing people! Nothing could compromise that!!
Indeed, very happy to see our paper highlighted by EACR!!!
We are very proud that our paper on using ML and ctDNA tumor burden quantitation to predict survival in metastatic breast cancer has been highlighted by @helloeacr.bsky.social!
Work led by @emmajb001.bsky.social in close collaboration with @ruedalab.bsky.social!
magazine.eacr.org/highlights-i...
Caldas Lab 🇵🇹🇮🇱🇪🇺🇬🇧
The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research.
